Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes
A minority of patients with hypertrophic cardiomyopathy (HCM) presents advanced heart failure (HF) during their clinical course, in the context of left ventricular (LV) remodeling with reduced LV ejection fraction (LVEF), or of severe diastolic dysfunction without impaired LVEF. Aim of this study was to describe a multicentric end stage (ES) HCM population and analyze clinical course and outcome among its different phenotypes.
Source: International Journal of Cardiology - Category: Cardiology Authors: Beatrice Musumeci, Giacomo Tini, Elena Biagini, Marco Merlo, Chiara Calore, Enrico Ammirati, Mattia Zampieri, Domitilla Russo, Giulia Grilli, Caterina Santolamazza, Riccardo Vio, Marta Rubino, Raffaello Ditaranto, Annamaria Del Franco, Paola Sormani, Vand Source Type: research
More News: Cardiology | Cardiomyopathy | Heart | Heart Failure | Hypertrophic Cardiomyopathy | Study